Circulating tumor DNA (ctDNA) informs clinical practice in patients with recurrent/metastatic gastroesophageal cancers.

医学 肿瘤科 内科学 阶段(地层学) 循环肿瘤DNA 队列 癌症 微小残留病 疾病 回顾性队列研究 生物 古生物学 白血病
作者
Rutika Jitesh Mehta,Samuel Rivero-Hinojosa,Farshid Dayyani,Joseph Chao,Jesus Izaguirre-Carbonell,Jenifer Ferguson,Bushra Shariff,Vasily N. Aushev,Griffin L. Budde,Shruti Sharma,Meenakshi Malhotra,Adham Adel Jurdi,MC Liu,Samuel Jacob Klempner,Brandon M. Huffman
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:41 (4_suppl): 427-427 被引量:2
标识
DOI:10.1200/jco.2023.41.4_suppl.427
摘要

427 Background: Gastric and esophageal cancers (GECs) together account for a significant global burden in terms of new diagnoses and deaths. Over the last several years, the utility of ctDNA has ranged from estimating tumor burden and characterizing the genomic landscape of tumor biology and response to therapy in the metastatic setting to detection of minimal residual disease (MRD) and cancer surveillance in the locally advanced setting. We have previously studied the role of a commercial ctDNA assay for MRD detection and surveillance in locally advanced GECs. Herein, we present our experience with the same ctDNA assay in advanced stage settings for GECs. Methods: In this retrospective analysis of real-world data obtained from commercial circulating tumor DNA (ctDNA) testing, 53 patients with recurrent/ metastatic esophageal cancer were analyzed. A total of 216 plasma samples were collected between 10/29/2008 and 08/23/2022. The patients were divided into 3 cohorts: Cohort A (N=30) included patients with stage II/III disease who had confirmed clinical recurrence (R). Cohort B (N=25) included recurrent and Stage IV patients who achieved a state of no evidence of disease (NED) on imaging. Cohort C (N=5) included recurrent and Stage IV patients who transiently achieved NED on imaging. A personalized, tumor-informed multiplex PCR-based next-generation sequencing assay (Signatera) was used to quantify ctDNA either postoperatively, on adjuvant or palliative therapy, or during active surveillance. Results: Of 53 patients, 30 patients with recurrent stage II/III esophageal cancer had ctDNA status available postoperatively within 150 days of confirmed clinical recurrence. Cohort A: Among these cases, 25 patients were ctDNA-positive ahead of clinical recurrence (sensitivity 83.3%) with a median of 31 days (range: 1-147 days). Cohort B: Next, we explored the correlation between ctDNA status and imaging, wherein, 96% (24/25) of patients showed a significant correlation between ctDNA status (positive or negative) and disease status by imaging (Fisher exact test p=0.0001). Of the 23 patients, 17 patients were ctDNA-negative and showed NED on imaging (negative predictive value of 100%; 17/17). Cohort C: 100% of patients (N=6) who demonstrated recurrent disease on imaging after NED were ctDNA-positive prior to imaging (positive predictive value of 100%). Conclusions: Our data demonstrate the utility of ctDNA in accurately predicting disease progression and support the potential use of ctDNA to inform treatment decisions or prompt early radiographic imaging. ctDNA may ultimately supersede traditional radiographic surveillance with the advantage of being minimally invasive and cost-effective in monitoring patients during/post-treatment.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI2S的应助被袁志阳采纳,获得10
刚刚
Crazy_Runner完成签到,获得积分10
刚刚
1秒前
1秒前
许可991127发布了新的文献求助10
1秒前
2秒前
慕青的应助被栗子卷采纳,获得10
2秒前
情怀的应助被MMMMathilda23采纳,获得10
2秒前
脑洞疼的应助被酷酷柚子采纳,获得10
3秒前
3秒前
叶心发布了新的文献求助10
3秒前
陈梓佳完成签到,获得积分10
4秒前
4秒前
4秒前
蛋又白发布了新的文献求助10
4秒前
Hiphone完成签到,获得积分10
5秒前
小蛇玩完成签到,获得积分10
5秒前
赘婿的应助被Zwj采纳,获得10
5秒前
Llt发布了新的文献求助10
6秒前
6秒前
duanhahaha发布了新的文献求助100
6秒前
研友_Z7gV2Z完成签到,获得积分10
7秒前
aaa完成签到,获得积分10
7秒前
7秒前
酷酷柚子发布了新的文献求助10
8秒前
王昊发布了新的文献求助10
8秒前
打打的应助被很好采纳,获得10
8秒前
9秒前
9秒前
10秒前
叶心完成签到,获得积分10
11秒前
笑点低醉波完成签到,获得积分10
11秒前
左江夜渔人完成签到,获得积分10
11秒前
mumu发布了新的文献求助30
12秒前
stoneff完成签到,获得积分10
12秒前
大雪纷飞发布了新的文献求助10
12秒前
SFC完成签到,获得积分10
12秒前
13秒前
13秒前
饱饱完成签到,获得积分10
14秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
Grapes 1000
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8178280
求助须知:如何正确求助?哪些是违规求助? 9569046
关于积分的说明 21802436
捐赠科研通 7773138
什么是DOI,文献DOI怎么找? 3432735
关于科研通互助平台的介绍 2556770
邀请新用户注册赠送积分活动 2478274